Herndon Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $12K | Hold |
96
| – | – | ﹤0.01% | 125 |
|
|
2017
Q1 | $13K | Buy |
+96
| New | +$13K | ﹤0.01% | 118 |
|
|
2016
Q3 | – | Sell |
-70
| Closed | -$7K | – | 613 |
|
|
2016
Q2 | $7K | Sell |
70
-255
| -78% | -$25.5K | ﹤0.01% | 209 |
|
|
2016
Q1 | $36K | Buy |
325
+317
| +3,963% | +$35.1K | ﹤0.01% | 163 |
|
|
2015
Q4 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 198 |
|
|
2015
Q2 | – | Sell |
-116
| Closed | -$19K | – | 209 |
|
|
2015
Q1 | $19K | Buy |
116
+16
| +16% | +$2.62K | ﹤0.01% | 153 |
|
|
2014
Q4 | $13K | Sell |
100
-1,123,576
| -100% | -$146M | ﹤0.01% | 156 |
|
|
2014
Q3 | $145M | Sell |
1,123,676
-39,146
| -3% | -$5.05M | 1.91% | 32 |
|
|
2014
Q2 | $103M | Buy |
1,162,822
+678,598
| +140% | +$60M | 1.29% | 37 |
|
|
2014
Q1 | $45.5M | Sell |
484,224
-1,406,003
| -74% | -$132M | 0.58% | 45 |
|
|
2013
Q4 | $214M | Buy |
1,890,227
+776,283
| +70% | +$87.8M | 2.7% | 8 |
|
|
2013
Q3 | $87.8M | Buy |
1,113,944
+89,039
| +9% | +$7.02M | 1.16% | 42 |
|
|
2013
Q2 | $67.5M | Buy |
+1,024,905
| New | +$67.5M | 1.01% | 46 |
|